The Opioids market is expected to grow from US$ 12.93 billion in 2023 to US$ 15.03 billion by 2031; it is anticipated to record a CAGR of 1.9% from 2023 to 2031. ![Opioids Market]( "Opioids Market")
Opioids are a broad group of medicines majorly used for relieving pain. These medicines are highly effective but can also leads to an addiction. Opioid acts by working on brain receptors and thus provide the varieties of effect including the pain relief. Opioid includes heroin, morphine, codeine, fentanyl, methadone, tramadol, and other similar substances. The growing opioids market size is attributed to the surging chronic pain incidences across the world. In addition, the increasing geriatric population across the world are fueling opioid market growth. A government initiative focusing on the development of medication to prevent and treat opioid overdose and disorders is likely to bring new opioids market trends during the forecast period.
Strategic Initiatives by Market Players will Create an Opportunity for Opioid market growth.
Opioids market players invest in R&D activities to ensure the development of effective products. In May 2023, Indivior PLC received the US Food and Drug Administration (FDA) approval for OPVEE (nalmefene) nasal spray for emergency use to treat suspected or known opioid overdose induced by synthetic or natural opioids in adults and pediatric patients aged 12 years and more, which is characterized by CNS and/or respiratory depression. Further, in December 2021, Sandoz announced the launch of its generic Narcan (naloxone hydrochloride) Nasal Spray 4mg in the US; the product is used to reverse opioid overdose. Individuals in the US can immediately obtain Narcan via retail pharmacies and institutions, including hospitals. Lastly, in August 2023, Emergent BioSolutions launched the over-the-counter NARCAN Nasal Spray, making it possible for everybody to help save a life from an opioid overdose emergency. Therefore, strategic initiatives are likely to offer growth opportunities to the opioids market in the coming years.
Based on geography, the Opioid market is segmented into North America (US, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, Southeast Asia, and Rest of Asia Pacific), the Middle East & Africa (UAE, Saudi Arabia, South Africa, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America). North America held the largest share of the global Opioid market in 2023 owing to the lifestyle factor. However, Asia Pacific is predicted to register the highest CAGR during 2023-2031. The US held the largest share of the Opioid market in North America in 2022. US market players are adopting organic and inorganic strategies for Opioid market development. For instance, in 2024, Hikma Pharmaceuticals PLC launched Fentanyl Citrate Injection, USP, in 25mcg/0.5mL and 50mcg/mL doses. Hikma introduced the first FDA approved 25mcg/0.5mL presentation to the US market. The company is expected to expand its portfolio with the launch, broadening the choice of medicines available to hospitals. Furthermore, in 2023, Rusan Pharma launched its state-of-the-art API facility in Madhya Pradesh, India. The facility is designed to meet stringent international regulatory guidelines, ensuring the highest level of compliance. With the production capability of 400 metric tons of APIs annually. This facility expansion will ensure the security of supply of critical APIs to meet the growing demand for addiction treatment and pain management products in India and globally. Moreover in 2023, Neuraxpharm announced the closing of the acquisition of two established product portfolios for CNS disorders, pain and vascular diseases from Sanofi. The well-established products that Neuraxpharm acquired includes 15 products addressing CNS disorders and two products in pain and vascular diseases, and in 2022, Collegium Pharmaceutical, Inc. announced that it completed the acquisition of BioDelivery Sciences International Inc. BDSI has a portfolio of pain and neurology products that address serious and debilitating conditions. BDSI’s commercial growth driver, BELBUCA, is a meaningfully differentiated schedule III opioid product and is highly complementary to Collegium’s portfolio of pain products. Thus, the factors mentioned above support the market growth.
Opioids are a broad group of medicines majorly used for relieving pain. These medicines are highly effective but can also leads to an addiction. Opioid acts by working on brain receptors and thus provide the varieties of effect including the pain relief. Opioid includes heroin, morphine, codeine, fentanyl, methadone, tramadol, and other similar substances. The growing opioids market size is attributed to the surging chronic pain incidences across the world. In addition, the increasing geriatric population across the world are fueling opioid market growth. A government initiative focusing on the development of medication to prevent and treat opioid overdose and disorders is likely to bring new opioids market trends during the forecast period.
Strategic Initiatives by Market Players will Create an Opportunity for Opioid market growth.
Opioids market players invest in R&D activities to ensure the development of effective products. In May 2023, Indivior PLC received the US Food and Drug Administration (FDA) approval for OPVEE (nalmefene) nasal spray for emergency use to treat suspected or known opioid overdose induced by synthetic or natural opioids in adults and pediatric patients aged 12 years and more, which is characterized by CNS and/or respiratory depression. Further, in December 2021, Sandoz announced the launch of its generic Narcan (naloxone hydrochloride) Nasal Spray 4mg in the US; the product is used to reverse opioid overdose. Individuals in the US can immediately obtain Narcan via retail pharmacies and institutions, including hospitals. Lastly, in August 2023, Emergent BioSolutions launched the over-the-counter NARCAN Nasal Spray, making it possible for everybody to help save a life from an opioid overdose emergency. Therefore, strategic initiatives are likely to offer growth opportunities to the opioids market in the coming years.
Based on geography, the Opioid market is segmented into North America (US, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, Southeast Asia, and Rest of Asia Pacific), the Middle East & Africa (UAE, Saudi Arabia, South Africa, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America). North America held the largest share of the global Opioid market in 2023 owing to the lifestyle factor. However, Asia Pacific is predicted to register the highest CAGR during 2023-2031. The US held the largest share of the Opioid market in North America in 2022. US market players are adopting organic and inorganic strategies for Opioid market development. For instance, in 2024, Hikma Pharmaceuticals PLC launched Fentanyl Citrate Injection, USP, in 25mcg/0.5mL and 50mcg/mL doses. Hikma introduced the first FDA approved 25mcg/0.5mL presentation to the US market. The company is expected to expand its portfolio with the launch, broadening the choice of medicines available to hospitals. Furthermore, in 2023, Rusan Pharma launched its state-of-the-art API facility in Madhya Pradesh, India. The facility is designed to meet stringent international regulatory guidelines, ensuring the highest level of compliance. With the production capability of 400 metric tons of APIs annually. This facility expansion will ensure the security of supply of critical APIs to meet the growing demand for addiction treatment and pain management products in India and globally. Moreover in 2023, Neuraxpharm announced the closing of the acquisition of two established product portfolios for CNS disorders, pain and vascular diseases from Sanofi. The well-established products that Neuraxpharm acquired includes 15 products addressing CNS disorders and two products in pain and vascular diseases, and in 2022, Collegium Pharmaceutical, Inc. announced that it completed the acquisition of BioDelivery Sciences International Inc. BDSI has a portfolio of pain and neurology products that address serious and debilitating conditions. BDSI’s commercial growth driver, BELBUCA, is a meaningfully differentiated schedule III opioid product and is highly complementary to Collegium’s portfolio of pain products. Thus, the factors mentioned above support the market growth.
Table of Contents
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
3.2 Secondary Research
3.3 Primary Research
4. Opioids Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2 PEST Analysis
5. Opioids Market - Key Market Dynamics
5.1 Opioids Market - Key Market Dynamics
5.2 Market Drivers
5.2.1 Surging Chronic Pain Incidence
5.2.2 Increasing Geriatric Population
5.3 Market Restraints
5.3.1 Increasing Drug Abuse
5.4 Market Opportunities
5.4.1 Strategic Initiatives by Market Players
5.5 Future Trends
5.5.1 Government Initiatives Focusing on Development of Medication to Prevent and Treat Opioid Overdose and Disorder
5.6 Impact of Drivers and Restraints:
5.2 Market Drivers
5.2.1 Surging Chronic Pain Incidence
5.2.2 Increasing Geriatric Population
5.3 Market Restraints
5.3.1 Increasing Drug Abuse
5.4 Market Opportunities
5.4.1 Strategic Initiatives by Market Players
5.5 Future Trends
5.5.1 Government Initiatives Focusing on Development of Medication to Prevent and Treat Opioid Overdose and Disorder
5.6 Impact of Drivers and Restraints:
6. Opioids Market - Global Market Analysis
6.1 Opioids Market Revenue (US$ Million), 2022-2030
6.2 Opioids Market Forecast Analysis
6.2 Opioids Market Forecast Analysis
7. Opioids Market Analysis - by Product
7.1 Immediate Release Short Acting Opioid
7.1.1 Overview
7.1.2 Immediate Release Short Acting Opioid: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.1 Global Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
7.2 Extended Release Long-Acting Opioid
7.2.1 Overview
7.2.2 Extended Release Long-Acting Opioid: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1 Global Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
7.1.1 Overview
7.1.2 Immediate Release Short Acting Opioid: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.1 Global Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
7.2 Extended Release Long-Acting Opioid
7.2.1 Overview
7.2.2 Extended Release Long-Acting Opioid: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1 Global Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
8. Opioids Market Analysis - by Application
8.1 Pain Management
8.1.1 Overview
8.1.2 Pain Management: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
8.2 Anesthesia
8.2.1 Overview
8.2.2 Anesthesia: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Diarrhoea Suppression
8.3.1 Overview
8.3.2 Diarrhoea Suppression: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Cough Suppression
8.4.1 Overview
8.4.2 Cough Suppression: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
8.5 De-Addiction
8.5.1 Overview
8.5.2 De-Addiction: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
8.1.1 Overview
8.1.2 Pain Management: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
8.2 Anesthesia
8.2.1 Overview
8.2.2 Anesthesia: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Diarrhoea Suppression
8.3.1 Overview
8.3.2 Diarrhoea Suppression: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Cough Suppression
8.4.1 Overview
8.4.2 Cough Suppression: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
8.5 De-Addiction
8.5.1 Overview
8.5.2 De-Addiction: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
9. Opioids Market Analysis - by Route of Administration
9.1 Oral
9.1.1 Overview
9.1.2 Oral: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
9.2 Injectable
9.2.1 Overview
9.2.2 Injectable: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
9.3 Transdermal Patch
9.3.1 Overview
9.3.2 Transdermal Patch: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1 Overview
9.1.2 Oral: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
9.2 Injectable
9.2.1 Overview
9.2.2 Injectable: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
9.3 Transdermal Patch
9.3.1 Overview
9.3.2 Transdermal Patch: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10. Opioids Market Analysis - by Distribution Channel
10.1 Hospital Pharmacies
10.1.1 Overview
10.1.2 Hospital Pharmacies: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.2 Retail Pharmacies
10.2.1 Overview
10.2.2 Retail Pharmacies: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1 Overview
10.1.2 Hospital Pharmacies: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.2 Retail Pharmacies
10.2.1 Overview
10.2.2 Retail Pharmacies: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
11. Opioids Market - Geographical Analysis
11.1 Overview
11.2 North America
11.2.1 North America Opioids Market Overview
11.2.2 North America: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
11.2.2.1 North America: Opioids Market - Revenue and Forecast Analysis - by Product
11.2.3 North America: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.2.3.1 North America: Opioids Market - Revenue and Forecast Analysis - by Immediate Release Short Acting Opioid
11.2.3.2 North America: Opioids Market - Revenue and Forecast Analysis - by Extended Release Long-Acting Opioid
11.2.3.3 North America: Opioids Market - Revenue and Forecast Analysis - by Application
11.2.4 North America: Opioids Market Breakdown, by Route of Administration
11.2.4.1 North America: Opioids Market - Revenue and Forecast Analysis - by Route of Administration
11.2.4.2 North America: Opioids Market - Revenue and Forecast Analysis - by Distribution Channel
11.2.5 North America: Opioids Market - Revenue and Forecast Analysis - by Country
11.2.5.1 North America: Opioids Market - Revenue and Forecast Analysis - by Country
11.2.5.2 United States: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
11.2.5.2.1 United States: Opioids Market Breakdown, by Product
11.2.5.2.2 United States: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.2.5.2.3 United States: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.2.5.2.4 United States: Opioids Market Breakdown, by Application
11.2.5.2.5 United States: Opioids Market Breakdown, by Route of Administration
11.2.5.2.6 United States: Opioids Market Breakdown, by Distribution Channel
11.2.5.3 Canada: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
11.2.5.3.1 Canada: Opioids Market Breakdown, by Product
11.2.5.3.2 Canada: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.2.5.3.3 Canada: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.2.5.3.4 Canada: Opioids Market Breakdown, by Application
11.2.5.3.5 Canada: Opioids Market Breakdown, by Route of Administration
11.2.5.3.6 Canada: Opioids Market Breakdown, by Distribution Channel
11.2.5.4 Mexico: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
11.2.5.4.1 Mexico: Opioids Market Breakdown, by Product
11.2.5.4.2 Mexico: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.2.5.4.3 Mexico: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.2.5.4.4 Mexico: Opioids Market Breakdown, by Application
11.2.5.4.5 Mexico: Opioids Market Breakdown, by Route of Administration
11.2.5.4.6 Mexico: Opioids Market Breakdown, by Distribution Channel
11.3 Europe
11.3.1 Europe Opioids Market Overview
11.3.2 Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
11.3.3 Europe: Opioids Market Breakdown, by Product
11.3.3.1 Europe: Opioids Market - Revenue and Forecast Analysis - by Product
11.3.3.2 Europe: Opioids Market - Revenue and Forecast Analysis - by Immediate Release Short Acting Opioid
11.3.3.3 Europe: Opioids Market - Revenue and Forecast Analysis - by Extended Release Long-Acting Opioid
11.3.3.4 Europe: Opioids Market - Revenue and Forecast Analysis - by Application
11.3.3.5 Europe: Opioids Market - Revenue and Forecast Analysis - by Route of Administration
11.3.3.6 Europe: Opioids Market - Revenue and Forecast Analysis - by Distribution Channel
11.3.4 Europe: Opioids Market - Revenue and Forecast Analysis - by Country
11.3.4.1 Europe: Opioids Market - Revenue and Forecast Analysis - by Country
11.3.4.2 United Kingdom: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
11.3.4.2.1 United Kingdom: Opioids Market Breakdown, by Product
11.3.4.2.2 United Kingdom: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.3.4.2.3 United Kingdom: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.3.4.2.4 United Kingdom: Opioids Market Breakdown, by Application
11.3.4.2.5 United Kingdom: Opioids Market Breakdown, by Route of Administration
11.3.4.2.6 United Kingdom: Opioids Market Breakdown, by Distribution Channel
11.3.4.3 Germany: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
11.3.4.3.1 Germany: Opioids Market Breakdown, by Product
11.3.4.3.2 Germany: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.3.4.3.3 Germany: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.3.4.3.4 Germany: Opioids Market Breakdown, by Application
11.3.4.3.5 Germany: Opioids Market Breakdown, by Route of Administration
11.3.4.3.6 Germany: Opioids Market Breakdown, by Distribution Channel
11.3.4.4 France: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
11.3.4.4.1 France: Opioids Market Breakdown, by Product
11.3.4.4.2 France: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.3.4.4.3 France: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.3.4.4.4 France: Opioids Market Breakdown, by Application
11.3.4.4.5 France: Opioids Market Breakdown, by Route of Administration
11.3.4.4.6 France: Opioids Market Breakdown, by Distribution Channel
11.3.4.5 Italy: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
11.3.4.5.1 Italy: Opioids Market Breakdown, by Product
11.3.4.5.2 Italy: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.3.4.5.3 Italy: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.3.4.5.4 Italy: Opioids Market Breakdown, by Application
11.3.4.5.5 Italy: Opioids Market Breakdown, by Route of Administration
11.3.4.5.6 Italy: Opioids Market Breakdown, by Distribution Channel
11.3.4.6 Spain: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
11.3.4.6.1 Spain: Opioids Market Breakdown, by Product
11.3.4.6.2 Spain: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.3.4.6.3 Spain: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.3.4.6.4 Spain: Opioids Market Breakdown, by Application
11.3.4.6.5 Spain: Opioids Market Breakdown, by Route of Administration
11.3.4.6.6 Spain: Opioids Market Breakdown, by Distribution Channel
11.3.4.7 Rest of Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
11.3.4.7.1 Rest of Europe: Opioids Market Breakdown, by Product
11.3.4.7.2 Rest of Europe: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.3.4.7.3 Rest of Europe: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.3.4.7.4 Rest of Europe: Opioids Market Breakdown, by Application
11.3.4.7.5 Rest of Europe: Opioids Market Breakdown, by Route of Administration
11.3.4.7.6 Rest of Europe: Opioids Market Breakdown, by Distribution Channel
11.4 Asia Pacific
11.4.1 Asia Pacific Opioids Market Overview
11.4.2 Asia Pacific: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
11.4.2.1 Asia Pacific: Opioids Market - Revenue and Forecast Analysis - by Product
11.4.2.2 Asia Pacific: Opioids Market - Revenue and Forecast Analysis - by Immediate Release Short Acting Opioid
11.4.2.3 Asia Pacific: Opioids Market - Revenue and Forecast Analysis - by Extended Release Long-Acting Opioid
11.4.2.4 Asia Pacific: Opioids Market - Revenue and Forecast Analysis - by Application
11.4.2.5 Asia Pacific: Opioids Market - Revenue and Forecast Analysis - by Route of Administration
11.4.2.6 Asia Pacific: Opioids Market - Revenue and Forecast Analysis - by Distribution Channel
11.4.3 Asia Pacific: Opioids Market - Revenue and Forecast Analysis - by Country
11.4.3.1 Asia Pacific: Opioids Market - Revenue and Forecast Analysis - by Country
11.4.3.2 China: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
11.4.3.2.1 China: Opioids Market Breakdown, by Product
11.4.3.2.2 China: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.4.3.2.3 China: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.4.3.2.4 China: Opioids Market Breakdown, by Application
11.4.3.2.5 China: Opioids Market Breakdown, by Route of Administration
11.4.3.2.6 China: Opioids Market Breakdown, by Distribution Channel
11.4.3.3 Japan: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
11.4.3.3.1 Japan: Opioids Market Breakdown, by Product
11.4.3.3.2 Japan: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.4.3.3.3 Japan: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.4.3.3.4 Japan: Opioids Market Breakdown, by Application
11.4.3.3.5 Japan: Opioids Market Breakdown, by Route of Administration
11.4.3.3.6 Japan: Opioids Market Breakdown, by Distribution Channel
11.4.3.4 India: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
11.4.3.4.1 India: Opioids Market Breakdown, by Product
11.4.3.4.2 India: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.4.3.4.3 India: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.4.3.4.4 India: Opioids Market Breakdown, by Application
11.4.3.4.5 India: Opioids Market Breakdown, by Route of Administration
11.4.3.4.6 India: Opioids Market Breakdown, by Distribution Channel
11.4.3.5 South Korea: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
11.4.3.5.1 South Korea: Opioids Market Breakdown, by Product
11.4.3.5.2 South Korea: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.4.3.5.3 South Korea: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.4.3.5.4 South Korea: Opioids Market Breakdown, by Application
11.4.3.5.5 South Korea: Opioids Market Breakdown, by Route of Administration
11.4.3.5.6 South Korea: Opioids Market Breakdown, by Distribution Channel
11.4.3.6 Australia: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
11.4.3.6.1 Australia: Opioids Market Breakdown, by Product
11.4.3.6.2 Australia: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.4.3.6.3 Australia: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.4.3.6.4 Australia: Opioids Market Breakdown, by Application
11.4.3.6.5 Australia: Opioids Market Breakdown, by Route of Administration
11.4.3.6.6 Australia: Opioids Market Breakdown, by Distribution Channel
11.4.3.7 Rest of APAC: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
11.4.3.7.1 Rest of APAC: Opioids Market Breakdown, by Product
11.4.3.7.2 Rest of APAC: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.4.3.7.3 Rest of APAC: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.4.3.7.4 Rest of APAC: Opioids Market Breakdown, by Application
11.4.3.7.5 Rest of APAC: Opioids Market Breakdown, by Route of Administration
11.4.3.7.6 Rest of APAC: Opioids Market Breakdown, by Distribution Channel
11.5 Middle East and Africa
11.5.1 Middle East and Africa Opioids Market Overview
11.5.2 Middle East and Africa: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
11.5.2.1 Middle East and Africa: Opioids Market - Revenue and Forecast Analysis - by Product
11.5.2.2 Middle East and Africa: Opioids Market - Revenue and Forecast Analysis - by Immediate Release Short Acting Opioid
11.5.2.3 Middle East and Africa: Opioids Market - Revenue and Forecast Analysis - by Extended Release Long-Acting Opioid
11.5.2.4 Middle East and Africa: Opioids Market - Revenue and Forecast Analysis - by Application
11.5.2.5 Middle East and Africa: Opioids Market - Revenue and Forecast Analysis - by Route of Administration
11.5.2.6 Middle East and Africa: Opioids Market - Revenue and Forecast Analysis - by Distribution Channel
11.5.2.7 Middle East and Africa: Opioids Market - Revenue and Forecast Analysis - by Country
11.5.2.8 Saudi Arabia: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
11.5.2.8.1 Saudi Arabia: Opioids Market Breakdown, by Product
11.5.2.8.2 Saudi Arabia: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.5.2.8.3 Saudi Arabia: Opioids Market Breakdown, by Extended Release Long Acting Opioid
11.5.2.8.4 Saudi Arabia: Opioids Market Breakdown, by Application
11.5.2.8.5 Saudi Arabia: Opioids Market Breakdown, by Route Of Administration
11.5.2.8.6 Saudi Arabia: Opioids Market Breakdown, by Distribution Channel
11.5.2.9 South Africa: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
11.5.2.9.1 South Africa: Opioids Market Breakdown, by Product
11.5.2.9.2 South Africa: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.5.2.9.3 South Africa: Opioids Market Breakdown, by Extended Release Long Acting Opioid
11.5.2.9.4 South Africa: Opioids Market Breakdown, by Application
11.5.2.9.5 South Africa: Opioids Market Breakdown, by Route Of Administration
11.5.2.9.6 South Africa: Opioids Market Breakdown, by Distribution Channel
11.5.2.10 United Arab Emirates: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
11.5.2.10.1 United Arab Emirates: Opioids Market Breakdown, by Product
11.5.2.10.2 United Arab Emirates: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.5.2.10.3 United Arab Emirates: Opioids Market Breakdown, by Extended Release Long Acting Opioid
11.5.2.10.4 United Arab Emirates: Opioids Market Breakdown, by Application
11.5.2.10.5 United Arab Emirates: Opioids Market Breakdown, by Route Of Administration
11.5.2.10.6 United Arab Emirates: Opioids Market Breakdown, by Distribution Channel
11.5.2.11 Rest of Middle East and Africa: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
11.5.2.11.1 Rest of Middle East and Africa: Opioids Market Breakdown, by Product
11.5.2.11.2 Rest of Middle East and Africa: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.5.2.11.3 Rest of Middle East and Africa: Opioids Market Breakdown, by Extended Release Long Acting Opioid
11.5.2.11.4 Rest of Middle East and Africa: Opioids Market Breakdown, by Application
11.5.2.11.5 Rest of Middle East and Africa: Opioids Market Breakdown, by Route Of Administration
11.5.2.11.6 Rest of Middle East and Africa: Opioids Market Breakdown, by Distribution Channel
11.6 South and Central America
11.6.1 South and Central America Opioids Market Overview
11.6.2 South and Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
11.6.2.1 South and Central America: Opioids Market - Revenue and Forecast Analysis - by Product
11.6.2.2 South and Central America: Opioids Market - Revenue and Forecast Analysis - by Immediate Release Short Acting Opioid
11.6.2.3 South and Central America: Opioids Market - Revenue and Forecast Analysis - by Extended Release Long Acting Opioid
11.6.2.4 South and Central America: Opioids Market - Revenue and Forecast Analysis - by Application
11.6.2.5 South and Central America: Opioids Market - Revenue and Forecast Analysis - by Route Of Administration
11.6.2.6 South and Central America: Opioids Market - Revenue and Forecast Analysis - by Distribution Channel
11.6.3 South and Central America: Opioids Market - Revenue and Forecast Analysis - by Country
11.6.3.1 South and Central America: Opioids Market - Revenue and Forecast Analysis - by Country
11.6.3.2 Brazil: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
11.6.3.2.1 Brazil: Opioids Market Breakdown, by Product
11.6.3.2.2 Brazil: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.6.3.2.3 Brazil: Opioids Market Breakdown, by Extended Release Long Acting Opioid
11.6.3.2.4 Brazil: Opioids Market Breakdown, by Application
11.6.3.2.5 Brazil: Opioids Market Breakdown, by Route Of Administration
11.6.3.2.6 Brazil: Opioids Market Breakdown, by Distribution Channel
11.6.3.3 Argentina: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
11.6.3.3.1 Argentina: Opioids Market Breakdown, by Product
11.6.3.3.2 Argentina: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.6.3.3.3 Argentina: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.6.3.3.4 Argentina: Opioids Market Breakdown, by Application
11.6.3.3.5 Argentina: Opioids Market Breakdown, by Route Of Administration
11.6.3.3.6 Argentina: Opioids Market Breakdown, by Distribution Channel
11.6.3.4 Rest of South and Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
11.6.3.4.1 Rest of South and Central America: Opioids Market Breakdown, by Product
11.6.3.4.2 Rest of South and Central America: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.6.3.4.3 Rest of South and Central America: Opioids Market Breakdown, by Extended Release Long Acting Opioid
11.6.3.4.4 Rest of South and Central America: Opioids Market Breakdown, by Application
11.6.3.4.5 Rest of South and Central America: Opioids Market Breakdown, by Route Of Administration
11.6.3.4.6 Rest of South and Central America: Opioids Market Breakdown, by Distribution Channel
11.2 North America
11.2.1 North America Opioids Market Overview
11.2.2 North America: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
11.2.2.1 North America: Opioids Market - Revenue and Forecast Analysis - by Product
11.2.3 North America: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.2.3.1 North America: Opioids Market - Revenue and Forecast Analysis - by Immediate Release Short Acting Opioid
11.2.3.2 North America: Opioids Market - Revenue and Forecast Analysis - by Extended Release Long-Acting Opioid
11.2.3.3 North America: Opioids Market - Revenue and Forecast Analysis - by Application
11.2.4 North America: Opioids Market Breakdown, by Route of Administration
11.2.4.1 North America: Opioids Market - Revenue and Forecast Analysis - by Route of Administration
11.2.4.2 North America: Opioids Market - Revenue and Forecast Analysis - by Distribution Channel
11.2.5 North America: Opioids Market - Revenue and Forecast Analysis - by Country
11.2.5.1 North America: Opioids Market - Revenue and Forecast Analysis - by Country
11.2.5.2 United States: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
11.2.5.2.1 United States: Opioids Market Breakdown, by Product
11.2.5.2.2 United States: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.2.5.2.3 United States: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.2.5.2.4 United States: Opioids Market Breakdown, by Application
11.2.5.2.5 United States: Opioids Market Breakdown, by Route of Administration
11.2.5.2.6 United States: Opioids Market Breakdown, by Distribution Channel
11.2.5.3 Canada: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
11.2.5.3.1 Canada: Opioids Market Breakdown, by Product
11.2.5.3.2 Canada: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.2.5.3.3 Canada: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.2.5.3.4 Canada: Opioids Market Breakdown, by Application
11.2.5.3.5 Canada: Opioids Market Breakdown, by Route of Administration
11.2.5.3.6 Canada: Opioids Market Breakdown, by Distribution Channel
11.2.5.4 Mexico: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
11.2.5.4.1 Mexico: Opioids Market Breakdown, by Product
11.2.5.4.2 Mexico: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.2.5.4.3 Mexico: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.2.5.4.4 Mexico: Opioids Market Breakdown, by Application
11.2.5.4.5 Mexico: Opioids Market Breakdown, by Route of Administration
11.2.5.4.6 Mexico: Opioids Market Breakdown, by Distribution Channel
11.3 Europe
11.3.1 Europe Opioids Market Overview
11.3.2 Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
11.3.3 Europe: Opioids Market Breakdown, by Product
11.3.3.1 Europe: Opioids Market - Revenue and Forecast Analysis - by Product
11.3.3.2 Europe: Opioids Market - Revenue and Forecast Analysis - by Immediate Release Short Acting Opioid
11.3.3.3 Europe: Opioids Market - Revenue and Forecast Analysis - by Extended Release Long-Acting Opioid
11.3.3.4 Europe: Opioids Market - Revenue and Forecast Analysis - by Application
11.3.3.5 Europe: Opioids Market - Revenue and Forecast Analysis - by Route of Administration
11.3.3.6 Europe: Opioids Market - Revenue and Forecast Analysis - by Distribution Channel
11.3.4 Europe: Opioids Market - Revenue and Forecast Analysis - by Country
11.3.4.1 Europe: Opioids Market - Revenue and Forecast Analysis - by Country
11.3.4.2 United Kingdom: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
11.3.4.2.1 United Kingdom: Opioids Market Breakdown, by Product
11.3.4.2.2 United Kingdom: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.3.4.2.3 United Kingdom: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.3.4.2.4 United Kingdom: Opioids Market Breakdown, by Application
11.3.4.2.5 United Kingdom: Opioids Market Breakdown, by Route of Administration
11.3.4.2.6 United Kingdom: Opioids Market Breakdown, by Distribution Channel
11.3.4.3 Germany: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
11.3.4.3.1 Germany: Opioids Market Breakdown, by Product
11.3.4.3.2 Germany: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.3.4.3.3 Germany: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.3.4.3.4 Germany: Opioids Market Breakdown, by Application
11.3.4.3.5 Germany: Opioids Market Breakdown, by Route of Administration
11.3.4.3.6 Germany: Opioids Market Breakdown, by Distribution Channel
11.3.4.4 France: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
11.3.4.4.1 France: Opioids Market Breakdown, by Product
11.3.4.4.2 France: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.3.4.4.3 France: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.3.4.4.4 France: Opioids Market Breakdown, by Application
11.3.4.4.5 France: Opioids Market Breakdown, by Route of Administration
11.3.4.4.6 France: Opioids Market Breakdown, by Distribution Channel
11.3.4.5 Italy: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
11.3.4.5.1 Italy: Opioids Market Breakdown, by Product
11.3.4.5.2 Italy: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.3.4.5.3 Italy: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.3.4.5.4 Italy: Opioids Market Breakdown, by Application
11.3.4.5.5 Italy: Opioids Market Breakdown, by Route of Administration
11.3.4.5.6 Italy: Opioids Market Breakdown, by Distribution Channel
11.3.4.6 Spain: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
11.3.4.6.1 Spain: Opioids Market Breakdown, by Product
11.3.4.6.2 Spain: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.3.4.6.3 Spain: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.3.4.6.4 Spain: Opioids Market Breakdown, by Application
11.3.4.6.5 Spain: Opioids Market Breakdown, by Route of Administration
11.3.4.6.6 Spain: Opioids Market Breakdown, by Distribution Channel
11.3.4.7 Rest of Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
11.3.4.7.1 Rest of Europe: Opioids Market Breakdown, by Product
11.3.4.7.2 Rest of Europe: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.3.4.7.3 Rest of Europe: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.3.4.7.4 Rest of Europe: Opioids Market Breakdown, by Application
11.3.4.7.5 Rest of Europe: Opioids Market Breakdown, by Route of Administration
11.3.4.7.6 Rest of Europe: Opioids Market Breakdown, by Distribution Channel
11.4 Asia Pacific
11.4.1 Asia Pacific Opioids Market Overview
11.4.2 Asia Pacific: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
11.4.2.1 Asia Pacific: Opioids Market - Revenue and Forecast Analysis - by Product
11.4.2.2 Asia Pacific: Opioids Market - Revenue and Forecast Analysis - by Immediate Release Short Acting Opioid
11.4.2.3 Asia Pacific: Opioids Market - Revenue and Forecast Analysis - by Extended Release Long-Acting Opioid
11.4.2.4 Asia Pacific: Opioids Market - Revenue and Forecast Analysis - by Application
11.4.2.5 Asia Pacific: Opioids Market - Revenue and Forecast Analysis - by Route of Administration
11.4.2.6 Asia Pacific: Opioids Market - Revenue and Forecast Analysis - by Distribution Channel
11.4.3 Asia Pacific: Opioids Market - Revenue and Forecast Analysis - by Country
11.4.3.1 Asia Pacific: Opioids Market - Revenue and Forecast Analysis - by Country
11.4.3.2 China: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
11.4.3.2.1 China: Opioids Market Breakdown, by Product
11.4.3.2.2 China: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.4.3.2.3 China: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.4.3.2.4 China: Opioids Market Breakdown, by Application
11.4.3.2.5 China: Opioids Market Breakdown, by Route of Administration
11.4.3.2.6 China: Opioids Market Breakdown, by Distribution Channel
11.4.3.3 Japan: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
11.4.3.3.1 Japan: Opioids Market Breakdown, by Product
11.4.3.3.2 Japan: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.4.3.3.3 Japan: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.4.3.3.4 Japan: Opioids Market Breakdown, by Application
11.4.3.3.5 Japan: Opioids Market Breakdown, by Route of Administration
11.4.3.3.6 Japan: Opioids Market Breakdown, by Distribution Channel
11.4.3.4 India: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
11.4.3.4.1 India: Opioids Market Breakdown, by Product
11.4.3.4.2 India: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.4.3.4.3 India: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.4.3.4.4 India: Opioids Market Breakdown, by Application
11.4.3.4.5 India: Opioids Market Breakdown, by Route of Administration
11.4.3.4.6 India: Opioids Market Breakdown, by Distribution Channel
11.4.3.5 South Korea: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
11.4.3.5.1 South Korea: Opioids Market Breakdown, by Product
11.4.3.5.2 South Korea: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.4.3.5.3 South Korea: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.4.3.5.4 South Korea: Opioids Market Breakdown, by Application
11.4.3.5.5 South Korea: Opioids Market Breakdown, by Route of Administration
11.4.3.5.6 South Korea: Opioids Market Breakdown, by Distribution Channel
11.4.3.6 Australia: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
11.4.3.6.1 Australia: Opioids Market Breakdown, by Product
11.4.3.6.2 Australia: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.4.3.6.3 Australia: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.4.3.6.4 Australia: Opioids Market Breakdown, by Application
11.4.3.6.5 Australia: Opioids Market Breakdown, by Route of Administration
11.4.3.6.6 Australia: Opioids Market Breakdown, by Distribution Channel
11.4.3.7 Rest of APAC: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
11.4.3.7.1 Rest of APAC: Opioids Market Breakdown, by Product
11.4.3.7.2 Rest of APAC: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.4.3.7.3 Rest of APAC: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.4.3.7.4 Rest of APAC: Opioids Market Breakdown, by Application
11.4.3.7.5 Rest of APAC: Opioids Market Breakdown, by Route of Administration
11.4.3.7.6 Rest of APAC: Opioids Market Breakdown, by Distribution Channel
11.5 Middle East and Africa
11.5.1 Middle East and Africa Opioids Market Overview
11.5.2 Middle East and Africa: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
11.5.2.1 Middle East and Africa: Opioids Market - Revenue and Forecast Analysis - by Product
11.5.2.2 Middle East and Africa: Opioids Market - Revenue and Forecast Analysis - by Immediate Release Short Acting Opioid
11.5.2.3 Middle East and Africa: Opioids Market - Revenue and Forecast Analysis - by Extended Release Long-Acting Opioid
11.5.2.4 Middle East and Africa: Opioids Market - Revenue and Forecast Analysis - by Application
11.5.2.5 Middle East and Africa: Opioids Market - Revenue and Forecast Analysis - by Route of Administration
11.5.2.6 Middle East and Africa: Opioids Market - Revenue and Forecast Analysis - by Distribution Channel
11.5.2.7 Middle East and Africa: Opioids Market - Revenue and Forecast Analysis - by Country
11.5.2.8 Saudi Arabia: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
11.5.2.8.1 Saudi Arabia: Opioids Market Breakdown, by Product
11.5.2.8.2 Saudi Arabia: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.5.2.8.3 Saudi Arabia: Opioids Market Breakdown, by Extended Release Long Acting Opioid
11.5.2.8.4 Saudi Arabia: Opioids Market Breakdown, by Application
11.5.2.8.5 Saudi Arabia: Opioids Market Breakdown, by Route Of Administration
11.5.2.8.6 Saudi Arabia: Opioids Market Breakdown, by Distribution Channel
11.5.2.9 South Africa: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
11.5.2.9.1 South Africa: Opioids Market Breakdown, by Product
11.5.2.9.2 South Africa: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.5.2.9.3 South Africa: Opioids Market Breakdown, by Extended Release Long Acting Opioid
11.5.2.9.4 South Africa: Opioids Market Breakdown, by Application
11.5.2.9.5 South Africa: Opioids Market Breakdown, by Route Of Administration
11.5.2.9.6 South Africa: Opioids Market Breakdown, by Distribution Channel
11.5.2.10 United Arab Emirates: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
11.5.2.10.1 United Arab Emirates: Opioids Market Breakdown, by Product
11.5.2.10.2 United Arab Emirates: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.5.2.10.3 United Arab Emirates: Opioids Market Breakdown, by Extended Release Long Acting Opioid
11.5.2.10.4 United Arab Emirates: Opioids Market Breakdown, by Application
11.5.2.10.5 United Arab Emirates: Opioids Market Breakdown, by Route Of Administration
11.5.2.10.6 United Arab Emirates: Opioids Market Breakdown, by Distribution Channel
11.5.2.11 Rest of Middle East and Africa: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
11.5.2.11.1 Rest of Middle East and Africa: Opioids Market Breakdown, by Product
11.5.2.11.2 Rest of Middle East and Africa: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.5.2.11.3 Rest of Middle East and Africa: Opioids Market Breakdown, by Extended Release Long Acting Opioid
11.5.2.11.4 Rest of Middle East and Africa: Opioids Market Breakdown, by Application
11.5.2.11.5 Rest of Middle East and Africa: Opioids Market Breakdown, by Route Of Administration
11.5.2.11.6 Rest of Middle East and Africa: Opioids Market Breakdown, by Distribution Channel
11.6 South and Central America
11.6.1 South and Central America Opioids Market Overview
11.6.2 South and Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
11.6.2.1 South and Central America: Opioids Market - Revenue and Forecast Analysis - by Product
11.6.2.2 South and Central America: Opioids Market - Revenue and Forecast Analysis - by Immediate Release Short Acting Opioid
11.6.2.3 South and Central America: Opioids Market - Revenue and Forecast Analysis - by Extended Release Long Acting Opioid
11.6.2.4 South and Central America: Opioids Market - Revenue and Forecast Analysis - by Application
11.6.2.5 South and Central America: Opioids Market - Revenue and Forecast Analysis - by Route Of Administration
11.6.2.6 South and Central America: Opioids Market - Revenue and Forecast Analysis - by Distribution Channel
11.6.3 South and Central America: Opioids Market - Revenue and Forecast Analysis - by Country
11.6.3.1 South and Central America: Opioids Market - Revenue and Forecast Analysis - by Country
11.6.3.2 Brazil: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
11.6.3.2.1 Brazil: Opioids Market Breakdown, by Product
11.6.3.2.2 Brazil: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.6.3.2.3 Brazil: Opioids Market Breakdown, by Extended Release Long Acting Opioid
11.6.3.2.4 Brazil: Opioids Market Breakdown, by Application
11.6.3.2.5 Brazil: Opioids Market Breakdown, by Route Of Administration
11.6.3.2.6 Brazil: Opioids Market Breakdown, by Distribution Channel
11.6.3.3 Argentina: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
11.6.3.3.1 Argentina: Opioids Market Breakdown, by Product
11.6.3.3.2 Argentina: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.6.3.3.3 Argentina: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.6.3.3.4 Argentina: Opioids Market Breakdown, by Application
11.6.3.3.5 Argentina: Opioids Market Breakdown, by Route Of Administration
11.6.3.3.6 Argentina: Opioids Market Breakdown, by Distribution Channel
11.6.3.4 Rest of South and Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
11.6.3.4.1 Rest of South and Central America: Opioids Market Breakdown, by Product
11.6.3.4.2 Rest of South and Central America: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.6.3.4.3 Rest of South and Central America: Opioids Market Breakdown, by Extended Release Long Acting Opioid
11.6.3.4.4 Rest of South and Central America: Opioids Market Breakdown, by Application
11.6.3.4.5 Rest of South and Central America: Opioids Market Breakdown, by Route Of Administration
11.6.3.4.6 Rest of South and Central America: Opioids Market Breakdown, by Distribution Channel
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies in Opioids Market
12.3 Organic Growth Strategies
12.3.1 Overview
12.4 Inorganic Growth Strategies
12.4.1 Overview
12.2 Growth Strategies in Opioids Market
12.3 Organic Growth Strategies
12.3.1 Overview
12.4 Inorganic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Purdue Pharma LP
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Endo International plc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Mallinckrodt Plc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Collegium Pharmaceutical Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Neuraxpharm Pharmaceuticals SL
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Hikma Pharmaceuticals Plc
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Mayne Pharma Group Ltd
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Rusan Pharma Ltd
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Trevena Inc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Teva Pharmaceutical Industries Ltd
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Endo International plc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Mallinckrodt Plc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Collegium Pharmaceutical Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Neuraxpharm Pharmaceuticals SL
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Hikma Pharmaceuticals Plc
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Mayne Pharma Group Ltd
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Rusan Pharma Ltd
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Trevena Inc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Teva Pharmaceutical Industries Ltd
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About the Publisher
14.2 Glossary of Terms
14.2 Glossary of Terms
List of Tables
Table 1. Opioids Market Segmentation
Table 2. Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Table 3. Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 4. Global Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 5. Global Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 6. Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 7. Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 8. Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 9. North America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 10. North America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
Table 11. North America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
Table 12. North America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 13. North America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 14. North America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 15. North America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Country
Table 16. United States: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 17. United States: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
Table 18. United States: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
Table 19. United States: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 20. United States: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 21. United States: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 22. Canada: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 23. Canada: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
Table 24. Canada: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
Table 25. Canada: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 26. Canada: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 27. Canada: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 28. Mexico: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 29. Mexico: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
Table 30. Mexico: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
Table 31. Mexico: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 32. Mexico: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 33. Mexico: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 34. Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 35. Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
Table 36. Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
Table 37. Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 38. Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 39. Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 40. Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Country
Table 41. United Kingdom: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 42. United Kingdom: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
Table 43. United Kingdom: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
Table 44. United Kingdom: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 45. United Kingdom: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 46. United Kingdom: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 47. Germany: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 48. Germany: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
Table 49. Germany: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
Table 50. Germany: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 51. Germany: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 52. Germany: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 53. France: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 54. France: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
Table 55. France: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
Table 56. France: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 57. France: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 58. France: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 59. Italy: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 60. Italy: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
Table 61. Italy: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
Table 62. Italy: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 63. Italy: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 64. Italy: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 65. Spain: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 66. Spain: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
Table 67. Spain: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
Table 68. Spain: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 69. Spain: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 70. Spain: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 71. Rest of Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 72. Rest of Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
Table 73. Rest of Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
Table 74. Rest of Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 75. Rest of Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 76. Rest of Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 77. Asia Pacific: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 78. Asia Pacific: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
Table 79. Asia Pacific: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
Table 80. Asia Pacific: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 81. Asia Pacific: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 82. Asia Pacific: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 83. Asia Pacific: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Country
Table 84. China: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 85. China: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
Table 86. China: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
Table 87. China: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 88. China: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 89. China: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 90. Japan: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 91. Japan: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
Table 92. Japan: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
Table 93. Japan: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 94. Japan: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 95. Japan: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 96. India: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 97. India: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
Table 98. India: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
Table 99. India: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 100. India: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 101. India: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 102. South Korea: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 103. South Korea: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
Table 104. South Korea: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
Table 105. South Korea: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 106. South Korea: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 107. South Korea: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 108. Australia: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 109. Australia: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
Table 110. Australia: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
Table 111. Australia: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 112. Australia: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 113. Australia: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 114. Rest of APAC: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 115. Rest of APAC: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
Table 116. Rest of APAC: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
Table 117. Rest of APAC: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 118. Rest of APAC: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 119. Rest of APAC: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 120. Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 121. Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
Table 122. Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
Table 123. Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 124. Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 125. Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 126. Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Country
Table 127. Saudi Arabia: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 128. Saudi Arabia: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
Table 129. Saudi Arabia: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long Acting Opioid
Table 130. Saudi Arabia: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 131. Saudi Arabia: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route Of Administration
Table 132. Saudi Arabia: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 133. South Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 134. South Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
Table 135. South Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long Acting Opioid
Table 136. South Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 137. South Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route Of Administration
Table 138. South Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 139. United Arab Emirates: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 140. United Arab Emirates: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
Table 141. United Arab Emirates: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long Acting Opioid
Table 142. United Arab Emirates: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 143. United Arab Emirates: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route Of Administration
Table 144. United Arab Emirates: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 145. Rest of Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 146. Rest of Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
Table 147. Rest of Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long Acting Opioid
Table 148. Rest of Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 149. Rest of Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route Of Administration
Table 150. Rest of Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 151. South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 152. South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
Table 153. South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long Acting Opioid
Table 154. South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 155. South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route Of Administration
Table 156. South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 157. South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Country
Table 158. Brazil: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 159. Brazil: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
Table 160. Brazil: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long Acting Opioid
Table 161. Brazil: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 162. Brazil: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route Of Administration
Table 163. Brazil: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 164. Argentina: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 165. Argentina: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
Table 166. Argentina: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
Table 167. Argentina: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 168. Argentina: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route Of Administration
Table 169. Argentina: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 170. Rest of South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 171. Rest of South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
Table 172. Rest of South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long Acting Opioid
Table 173. Rest of South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 174. Rest of South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route Of Administration
Table 175. Rest of South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 176. Recent Organic Growth Strategies in Opioids Market
Table 177. Recent Inorganic Growth Strategies in the Opioids Market
Table 178. Glossary of Terms, Opioids Market
Table 2. Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Table 3. Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 4. Global Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 5. Global Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 6. Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 7. Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 8. Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 9. North America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 10. North America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
Table 11. North America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
Table 12. North America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 13. North America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 14. North America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 15. North America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Country
Table 16. United States: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 17. United States: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
Table 18. United States: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
Table 19. United States: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 20. United States: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 21. United States: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 22. Canada: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 23. Canada: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
Table 24. Canada: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
Table 25. Canada: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 26. Canada: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 27. Canada: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 28. Mexico: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 29. Mexico: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
Table 30. Mexico: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
Table 31. Mexico: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 32. Mexico: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 33. Mexico: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 34. Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 35. Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
Table 36. Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
Table 37. Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 38. Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 39. Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 40. Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Country
Table 41. United Kingdom: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 42. United Kingdom: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
Table 43. United Kingdom: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
Table 44. United Kingdom: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 45. United Kingdom: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 46. United Kingdom: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 47. Germany: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 48. Germany: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
Table 49. Germany: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
Table 50. Germany: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 51. Germany: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 52. Germany: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 53. France: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 54. France: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
Table 55. France: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
Table 56. France: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 57. France: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 58. France: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 59. Italy: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 60. Italy: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
Table 61. Italy: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
Table 62. Italy: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 63. Italy: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 64. Italy: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 65. Spain: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 66. Spain: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
Table 67. Spain: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
Table 68. Spain: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 69. Spain: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 70. Spain: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 71. Rest of Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 72. Rest of Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
Table 73. Rest of Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
Table 74. Rest of Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 75. Rest of Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 76. Rest of Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 77. Asia Pacific: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 78. Asia Pacific: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
Table 79. Asia Pacific: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
Table 80. Asia Pacific: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 81. Asia Pacific: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 82. Asia Pacific: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 83. Asia Pacific: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Country
Table 84. China: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 85. China: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
Table 86. China: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
Table 87. China: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 88. China: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 89. China: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 90. Japan: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 91. Japan: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
Table 92. Japan: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
Table 93. Japan: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 94. Japan: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 95. Japan: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 96. India: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 97. India: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
Table 98. India: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
Table 99. India: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 100. India: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 101. India: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 102. South Korea: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 103. South Korea: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
Table 104. South Korea: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
Table 105. South Korea: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 106. South Korea: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 107. South Korea: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 108. Australia: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 109. Australia: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
Table 110. Australia: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
Table 111. Australia: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 112. Australia: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 113. Australia: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 114. Rest of APAC: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 115. Rest of APAC: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
Table 116. Rest of APAC: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
Table 117. Rest of APAC: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 118. Rest of APAC: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 119. Rest of APAC: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 120. Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 121. Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
Table 122. Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
Table 123. Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 124. Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 125. Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 126. Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Country
Table 127. Saudi Arabia: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 128. Saudi Arabia: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
Table 129. Saudi Arabia: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long Acting Opioid
Table 130. Saudi Arabia: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 131. Saudi Arabia: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route Of Administration
Table 132. Saudi Arabia: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 133. South Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 134. South Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
Table 135. South Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long Acting Opioid
Table 136. South Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 137. South Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route Of Administration
Table 138. South Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 139. United Arab Emirates: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 140. United Arab Emirates: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
Table 141. United Arab Emirates: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long Acting Opioid
Table 142. United Arab Emirates: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 143. United Arab Emirates: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route Of Administration
Table 144. United Arab Emirates: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 145. Rest of Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 146. Rest of Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
Table 147. Rest of Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long Acting Opioid
Table 148. Rest of Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 149. Rest of Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route Of Administration
Table 150. Rest of Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 151. South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 152. South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
Table 153. South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long Acting Opioid
Table 154. South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 155. South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route Of Administration
Table 156. South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 157. South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Country
Table 158. Brazil: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 159. Brazil: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
Table 160. Brazil: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long Acting Opioid
Table 161. Brazil: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 162. Brazil: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route Of Administration
Table 163. Brazil: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 164. Argentina: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 165. Argentina: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
Table 166. Argentina: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
Table 167. Argentina: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 168. Argentina: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route Of Administration
Table 169. Argentina: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 170. Rest of South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 171. Rest of South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
Table 172. Rest of South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long Acting Opioid
Table 173. Rest of South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 174. Rest of South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route Of Administration
Table 175. Rest of South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 176. Recent Organic Growth Strategies in Opioids Market
Table 177. Recent Inorganic Growth Strategies in the Opioids Market
Table 178. Glossary of Terms, Opioids Market
List of Tables
Figure 1. Opioids Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Opioids Market Revenue (US$ Million), 2022-2030
Figure 5. Opioids Market Breakdown by Geography, 2022 and 2030 (%)
Figure 6. Opioids Market Share (%) - by Product (2022 and 2030)
Figure 7. Immediate Release Short Acting Opioid: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Extended Release Long-Acting Opioid: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Opioids Market Share (%) - by Application (2022 and 2030)
Figure 10. Pain Management: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Anesthesia: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Diarrhoea Suppression: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Cough Suppression: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. De-Addiction: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Others: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Opioids Market Share (%) - by Route of Administration (2022 and 2030)
Figure 17. Oral: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Injectable: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Transdermal Patch: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Opioids Market Share (%) - by Distribution Channel (2022 and 2030)
Figure 21. Hospital Pharmacies: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Retail Pharmacies: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Opioids Market Breakdown by Region, 2022 and 2030 (%)
Figure 24. North America: Opioids Market - Revenue and Forecast to 2030(US$ Million)
Figure 25. North America: Opioids Market Breakdown, by Route of Administration (2022 and 2030)
Figure 26. North America: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 27. United States: Opioids Market - Revenue and Forecast to 2030(US$ Million)
Figure 28. Canada: Opioids Market - Revenue and Forecast to 2030(US$ Million)
Figure 29. Mexico: Opioids Market - Revenue and Forecast to 2030(US$ Million)
Figure 30. Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million)
Figure 31. Europe: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 32. United Kingdom: Opioids Market - Revenue and Forecast to 2030(US$ Million)
Figure 33. Germany: Opioids Market - Revenue and Forecast to 2030(US$ Million)
Figure 34. France: Opioids Market - Revenue and Forecast to 2030(US$ Million)
Figure 35. Italy: Opioids Market - Revenue and Forecast to 2030(US$ Million)
Figure 36. Spain: Opioids Market - Revenue and Forecast to 2030(US$ Million)
Figure 37. Rest of Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million)
Figure 38. Asia Pacific: Opioids Market - Revenue and Forecast to 2030(US$ Million)
Figure 39. Asia Pacific: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 40. China: Opioids Market - Revenue and Forecast to 2030(US$ Million)
Figure 41. Japan: Opioids Market - Revenue and Forecast to 2030(US$ Million)
Figure 42. India: Opioids Market - Revenue and Forecast to 2030(US$ Million)
Figure 43. South Korea: Opioids Market - Revenue and Forecast to 2030(US$ Million)
Figure 44. Australia: Opioids Market - Revenue and Forecast to 2030(US$ Million)
Figure 45. Rest of APAC: Opioids Market - Revenue and Forecast to 2030(US$ Million)
Figure 46. Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million)
Figure 47. Saudi Arabia: Opioids Market - Revenue and Forecast to 2030(US$ Million)
Figure 48. South Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million)
Figure 49. United Arab Emirates: Opioids Market - Revenue and Forecast to 2030(US$ Million)
Figure 50. Rest of Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million)
Figure 51. South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million)
Figure 52. South and Central America: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 53. Brazil: Opioids Market - Revenue and Forecast to 2030(US$ Million)
Figure 54. Argentina: Opioids Market - Revenue and Forecast to 2030(US$ Million)
Figure 55. Rest of South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million)
Figure 56. Growth Strategies in Opioids Market
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Opioids Market Revenue (US$ Million), 2022-2030
Figure 5. Opioids Market Breakdown by Geography, 2022 and 2030 (%)
Figure 6. Opioids Market Share (%) - by Product (2022 and 2030)
Figure 7. Immediate Release Short Acting Opioid: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Extended Release Long-Acting Opioid: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Opioids Market Share (%) - by Application (2022 and 2030)
Figure 10. Pain Management: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Anesthesia: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Diarrhoea Suppression: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Cough Suppression: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. De-Addiction: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Others: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Opioids Market Share (%) - by Route of Administration (2022 and 2030)
Figure 17. Oral: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Injectable: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Transdermal Patch: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Opioids Market Share (%) - by Distribution Channel (2022 and 2030)
Figure 21. Hospital Pharmacies: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Retail Pharmacies: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Opioids Market Breakdown by Region, 2022 and 2030 (%)
Figure 24. North America: Opioids Market - Revenue and Forecast to 2030(US$ Million)
Figure 25. North America: Opioids Market Breakdown, by Route of Administration (2022 and 2030)
Figure 26. North America: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 27. United States: Opioids Market - Revenue and Forecast to 2030(US$ Million)
Figure 28. Canada: Opioids Market - Revenue and Forecast to 2030(US$ Million)
Figure 29. Mexico: Opioids Market - Revenue and Forecast to 2030(US$ Million)
Figure 30. Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million)
Figure 31. Europe: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 32. United Kingdom: Opioids Market - Revenue and Forecast to 2030(US$ Million)
Figure 33. Germany: Opioids Market - Revenue and Forecast to 2030(US$ Million)
Figure 34. France: Opioids Market - Revenue and Forecast to 2030(US$ Million)
Figure 35. Italy: Opioids Market - Revenue and Forecast to 2030(US$ Million)
Figure 36. Spain: Opioids Market - Revenue and Forecast to 2030(US$ Million)
Figure 37. Rest of Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million)
Figure 38. Asia Pacific: Opioids Market - Revenue and Forecast to 2030(US$ Million)
Figure 39. Asia Pacific: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 40. China: Opioids Market - Revenue and Forecast to 2030(US$ Million)
Figure 41. Japan: Opioids Market - Revenue and Forecast to 2030(US$ Million)
Figure 42. India: Opioids Market - Revenue and Forecast to 2030(US$ Million)
Figure 43. South Korea: Opioids Market - Revenue and Forecast to 2030(US$ Million)
Figure 44. Australia: Opioids Market - Revenue and Forecast to 2030(US$ Million)
Figure 45. Rest of APAC: Opioids Market - Revenue and Forecast to 2030(US$ Million)
Figure 46. Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million)
Figure 47. Saudi Arabia: Opioids Market - Revenue and Forecast to 2030(US$ Million)
Figure 48. South Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million)
Figure 49. United Arab Emirates: Opioids Market - Revenue and Forecast to 2030(US$ Million)
Figure 50. Rest of Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million)
Figure 51. South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million)
Figure 52. South and Central America: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 53. Brazil: Opioids Market - Revenue and Forecast to 2030(US$ Million)
Figure 54. Argentina: Opioids Market - Revenue and Forecast to 2030(US$ Million)
Figure 55. Rest of South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million)
Figure 56. Growth Strategies in Opioids Market
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Purdue Pharma LP
- Endo International plc
- Mallinckrodt Plc
- Collegium Pharmaceutical Inc
- Neuraxpharm Pharmaceuticals SL
- Hikma Pharmaceuticals Plc
- Mayne Pharma Group Ltd
- Rusan Pharma Ltd
- Trevena Inc
- Teva Pharmaceutical Industries Ltd
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 209 |
| Published | May 2024 |
| Forecast Period | 2023 - 2031 |
| Estimated Market Value ( USD | $ 12.93 Billion |
| Forecasted Market Value ( USD | $ 15.03 Billion |
| Compound Annual Growth Rate | 1.9% |
| Regions Covered | Global |
